Satellos Bioscience News and Activities

Satellos Bioscience is a company listed under the stock ticker MSCLF (US).

View the org chart displaying its 19 main executives

Most searched biographies at Satellos Bioscience

• Frank Gleeson, Chief Executive Officer and Director
• Adam Mostafa, Director
• Stephanie Brown, Director

Popular executive movements at Satellos Bioscience

• Antoinette Paone has joined the company as Chief Development Officer and Head of Regulatory Affairs  (posted on January 29 2026).
• Mark Nawacki has joined the company as Director  (posted on November 14 2025).

Create your alert
to follow the executive moves at Satellos Bioscience.

Satellos Bioscience has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).
• NewLimit has just announced a $435 Million fundraising (posted on June 3 2026).
• Rallybio and Avenzo Therapeutics have announced they will merge  (posted on June 1 2026)..

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Valerie Hanote - Non-Executive Director at Eurofins

Learn more about the Biotechnology industry

Press releases by Satellos Bioscience

• An Ottawa scientist's discovery offers rare hope for patients with devastating genetic disease
• Satellos Announces Dosing of First Participant in Phase 1 Clinical Study of SAT-3247
• Satellos Receives Rare Pediatric Disease Designation from the U.S. FDA for SAT-3247 for the Treatment of Duchenne Muscular Dystrophy
• Satellos to commence Phase I trial for DMD drug
• Satellos Receives Company of the Year Award from Life Sciences Ontario - Satellos

Social media about Satellos Bioscience

• Satellos Bioscience on Wikipedia, Google News & Yahoo Finance
• Satellos Bioscience on LinkedIn, X (Twitter) & YouTube